By inhibiting the overexpression of NgR1, RhoA, and ROCK2, neuroprotective effects were provided in a rat model of cerebral ischemia and in SH-SY5Y cells exposed to oxygen/glucose deprivation injury. The gene discussed is RHOA; the disease is Cerebral ischemia.